BiotechTube

Riluzole Oral Soluble Film

Phase 2Withdrawn
1 views this week 0 watching💤 Quiet
Interest: 21/100
21
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

ALS

Conditions

ALS

Trial Timeline

Mar 1, 2018 → Mar 27, 2018

NCT ID
NCT03457753

About Riluzole Oral Soluble Film

Riluzole Oral Soluble Film is a phase 2 stage product being developed by Aquestive Therapeutics for ALS. The current trial status is withdrawn. This product is registered under clinical trial identifier NCT03457753. Target conditions include ALS.

What happened to similar drugs?

4 of 12 similar drugs in ALS were approved

Approved (4) Terminated (0) Active (8)
🔄Oral Glycopyrrolate LiquidShionogiPhase 3
✅DonepezilEisaiApproved
✅Prednisolone + placebo + Valaciclovir + placebo + Prednisolone + valaciclovir + Placebo + placeboPfizerApproved
✅Escitalopram + Placebo oral tabletLundbeckApproved
🔄TofersenBiogenPhase 3
🔄Botulinum toxin type A + PlaceboIpsenPhase 3
🔄Botulinum toxin type AIpsenPhase 3

Hype Score Breakdown

Clinical
12
Activity
0
Company
9
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT03457753Phase 2Withdrawn

Competing Products

20 competing products in ALS

See all competitors
ProductCompanyStageHype Score
Oral Glycopyrrolate LiquidShionogiPhase 3
40
E0302 (mecobalamin)EisaiPhase 2/3
38
DonepezilEisaiApproved
43
E0302 (mecobalamin) + E0302 (mecobalamin) + PlaceboEisaiPhase 2/3
38
ONO-2506POOno PharmaceuticalPhase 2
35
ONO-2506PO + ONO-2506POOno PharmaceuticalPhase 2
35
LY4256984 + PlaceboEli LillyPhase 1
36
Racecadotril Film-Coated Tablet (FCT) + Racecadotril CapsuleJohnson & JohnsonPhase 1
29
UDI-001Rohto PharmaceuticalPhase 1/2
32
ABBV-8E12 + Placebo solution for IV infusion on Day 15AbbViePhase 2
27
Placebo + ABBV-8E12AbbViePhase 2
27
Fosigotifator + PlaceboAbbViePhase 1
21
ABBV-8E12AbbViePhase 1
29
antisense oligonucleotide + placeboNovartisPhase 1
29
VHB937NovartisPhase 2
39
Ranolazine 500 MG + Ranolazine 1000 MGGilead SciencesPhase 2
35
Prednisolone + placebo + Valaciclovir + placebo + Prednisolone + valaciclovir + Placebo + placeboPfizerApproved
43
BMS-933043 + Placebo matching with BMS-933043 + Antacid Buffer Predose SolutionBristol Myers SquibbPhase 1
29
Rifabutin + Rifabutin + Atazanavir + RitonavirBristol Myers SquibbPhase 1
29
ALN-SOD + Placebo (PB)Regeneron PharmaceuticalsPhase 1/2
39